Therefore, the IHC results confirmed that the three selected proteins appear over-expressed in IgAN vs. healthy controls, but neither CAP1, SHC1 nor PRCP appear significantly upregulated in the kidney tissue of IgAN patients compared to patients with other glomerular diseases. This evidence concerns the gene CAP1 and glomerular disorder.